» Articles » PMID: 2567317

The Evolution of MHC Restrictions in Antigen Recognition by T Cells in a Haploidentical Bone Marrow Transplant Recipient

Overview
Journal J Immunol
Date 1989 Jul 1
PMID 2567317
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We have longitudinally followed the major histocompatibility complex (MHC) restrictions that govern the response of T lymphocytes to specific Ag in a child with severe combined immunodeficiency who was successfully transplanted by using T cell depleted haploidentical maternal bone marrow cells and immunized shortly afterwards with tetanus toxoid (TT) Ag. In the first year post-transplant, monocytes were of both donor and recipient origin whereas T and B cells were of donor origin. Three years after transplant, all monocytes and T and B cells were of donor origin. T lymphocytes taken from the child at that time and depleted in vitro of alloreactivity to paternal Ag proliferated in response to TT presented by maternal as well as paternal monocytes. A TT-specific T cell line established from these cells in the presence of maternal monocytes cooperated with maternal but not with paternal monocytes, whereas a TT-specific T cell line established in the presence of paternal monocytes cooperated with paternal but not with maternal monocytes and with monocytes derived from a paternal uncle who shared the haplotype inherited by the recipient from her father. These results show that long-term memory T cells restricted to recipient MHC Ag not shared with the bone marrow donor continue to circulate long after the disappearance of accessory cells of recipient origin. These T cells could potentially participate in a secondary immune response because they were shown to recognize TT presented by recipient fibroblasts induced to express class II MHC molecules following treatment with IFN-gamma.

Citing Articles

Cytomegalovirus-specific T cells following haploidentical transplants: reshaping a repertoire by half.

OReilly R, Molvi Z Haematologica. 2022; 108(6):1461-1462.

PMID: 36453111 PMC: 10230411. DOI: 10.3324/haematol.2022.282132.


Stem cell transplantation for immunodeficiency.

Fischer A, Haddad E, Jabado N, Casanova J, Blanche S, Le Deist F Springer Semin Immunopathol. 1998; 19(4):479-92.

PMID: 9618769 DOI: 10.1007/BF00792603.


Mixed hematopoietic chimerism and transplantation tolerance.

Nikolic B, Sykes M Immunol Res. 1997; 16(3):217-28.

PMID: 9379073 DOI: 10.1007/BF02786391.


Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

Bacchetta R, Vandekerckhove B, Touraine J, Bigler M, Martino S, Gebuhrer L J Clin Invest. 1993; 91(3):1067-78.

PMID: 8450037 PMC: 288061. DOI: 10.1172/JCI116264.


Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.

Benkerrou M, Wara D, Elder M, Dror Y, Merino A, Colombe B J Clin Immunol. 1994; 14(2):98-106.

PMID: 8195318 DOI: 10.1007/BF01541342.